Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration?Guselkumab loss of exclusitivy?Xiaflex market launch year?Atorvastatin side effects heart palpitations?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for Entresto
Entresto (sacubitril/valsartan) received initial FDA approval on July 7, 2015. [1]
The date above is the FDA’s first approval in the United States. Other countries typically have different approval dates under their local regulators and review timelines.
For the FDA approval date and related patent/exclusivity timelines, DrugPatentWatch.com tracks drug history and can be used to cross-check key milestones. [1]
[1] https://www.drugpatentwatch.com/entresto/
Other Questions About Entresto :